← All peptidesPDA-V1 attestation Used in protocols Citations
verifiedBioGate · GREENGrade B
CJC-1295 (with DAC)
YADAIFTNSYRKVLGQLSARKLLQDIMSRLong-acting GHRH analog with Drug Affinity Complex; binds serum albumin for ~8-day half-life.
D-Ala²Gln⁸Ala¹⁵Leu²⁷MPA-DAC C-terminal
MW
3367.95
Length
29aa
Posterior
35.0%
Structural preview · ESMFold-2 mockdeterministic per sequence
Backbone preview · D-Ala²
Cryptographic chain of custody.
- Outer PDA hash
- Inputs hash
- Merkle root
- TEE attestation
- Protocol version
- PDA-V1
- Source
- peptide-md
- Model version
- structure-fm-2026.04
- Candidates emitted
- 3
- Signed
- 2026-04-21T08:14:33Z
Verifiable in your browser at /verifier with
@peptide-md/verifier.Real-world evidence
Cohort-attested outcomes.
Cohorts
3
Participants
415
Mean Δ
+7.82
Δ HRV ms (8-week) · 95% CI [6.43, 9.22]
IPNFT · Molecule IPNFT V2Solana
CJC-1295 (with DAC)
cb7d68…1dce7dRoyalty cascade
3.97%
Holders
380
Royalty cascade routes lab fees, licensing, and OEA-attested cohort revenues back to holders, the cohort treasury, and the originating researchers in a 60 / 25 / 15 split.
Where this peptide shows up.
Source literature.
Grade A2006 · J Clin Endocrinol Metab
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295
Teichman SL et al.